Correlates of outcome and response to IVIg in 88 patients with multifocal motor neuropathy
The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Identification and examination of all patients with multifocal motor neuropathy (MMN) in the Netherlands to document the clinical spectrum and response to IV immunoglobulin (IVIg) and to determine correlates of outcome. METHODS: A national cross-sectional descriptive study was performed. Ninety-seven patients were identified; 88 participated. Logistic regression analysis was used to study determinants of outcome. RESULTS: Age at onset was younger in men than in women (38 vs 45 years, p = 0.05). Onset of weakness was in distal arm (61%) or distal leg (34%), and occasionally in the upper arm (5%). Initial diagnosis was motor neuron disease in one-third of patients. Brisk, but not pathologic, reflexes in weakened muscles were found in 8%. Conduction blocks were most frequently detected in the ulnar (80%) and median (77%) nerves, but occasionally only between Erb and axilla (6%), or in the musculocutaneous nerve (1%). Ninety-four percent responded to IVIg therapy: nonresponders had longer disease duration before the first treatment (p = 0.03). Seventy-six percent received IVIg maintenance treatment at the time of this study (median duration 6 years; range 0-17): the median dose increased over the years from 12 to 17 g per week (p < 0.01). Independent determinants of more severe weakness and disability were axon loss (p < 0.001; p < 0.0001) and longer disease duration without IVIg (p = 0.03; p = 0.07). CONCLUSION: The results of this study may help aid recognition the clinical picture of MMN. Early IVIg treatment may help to postpone axonal degeneration and permanent deficits. CLASSIFICATION OF EVIDENCE: This study provides Class IV evidence that IVIg improves muscle strength of patients with MMN and disability (defined as an increase of >or=1 Medical Research Council grade in at least 2 muscle groups without decrease in other muscle groups) in 94% (95% confidence interval, 86.8%-97.4%) of patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Krupp, L. B. (1989) · Archives of Neurology · doi:10.1001/archneur.1989.00520460115022 · Cited by 6,172 · cited 1×
“Elbow extension 61 (69) 25 (28) 2 (2) 4.”
A treatable multifocal motor neuropathy with antibodies to GM1 ganglioside
Pestronk, A., Cornblath, D. R., Ilyas, A. A., Baba, H., Quarles, R. H., Griffin, J. W., Alderson, K., & Adams, R. N. (1988) · Annals of Neurology · doi:10.1002/ana.410240113 · Cited by 609 · cited 1×
“Elbow extension 61 (69) 25 (28) 2 (2) 4.”
Multifocal acquired demyelinating neuropathy masqurading as motor neuron disease
Parry, G. J., & Clarke, S. (1988) · Muscle & Nerve · doi:10.1002/mus.880110203 · Cited by 286
Martina, I. S. J., van Koningsveld, R., Schmitz, P. I. M., van der Meche, F. G. A., & van Doorn, P. A. (1998) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.65.5.743 · Cited by 286
Self-citationFatigue in immune-mediated polyneuropathies
Merkies, I. S. J., Schmitz, P. I. M., Samijn, J. P. A., van der Meché, F. G. A., & van Doorn, P. A. (1999) · Neurology · doi:10.1212/wnl.53.8.1648 · Cited by 277
Self-citationVan den Berg, L. H., Kerkhoff, H., Oey, P. L., Franssen, H., Mollee, I., Vermeulen, M., Jennekens, F. G., & Wokke, J. H. (1995) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.59.3.248 · Cited by 254
Self-citationConsensus criteria for the diagnosis of multifocal motor neuropathy
Olney, R. K., Lewis, R. A., Putnam, T. D., & Campellone, J. V. (2003) · Muscle & Nerve · doi:10.1002/mus.10317 · Cited by 218
Multifocal motor neuropathy: Response to human immune globulin
Chaudhry, V., Corse, A. M., Cornblath, D. R., Kuncl, R. W., Drachman, D. B., Freimer, M. L., Miller, R. G., & Griffin, J. W. (1993) · Annals of Neurology · doi:10.1002/ana.410330303 · Cited by 218 · cited 2×
“Elbow flexion 58 (66) 27 (31) 3 (3) 4.”
Hattori, N., Yamamoto, M., Yoshihara, T., Koike, H., Nakagawa, M., Yoshikawa, H., Ohnishi, A., Hayasaka, K., Onodera, O., Baba, M., et al. (2002) · Brain · doi:10.1093/brain/awg012 · Cited by 218 · cited 1×
“Foot dorsal flexion 28 (32) 37 (42) 23 (26) 3.”
Nobile-Orazio, E. (2001) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(01)00266-1 · Cited by 195
Multifocal motor neuropathy: Current concepts and controversies
Nobile‐Orazio, E., Cappellari, A. M., & Priori, A. (2005) · Muscle & Nerve · doi:10.1002/mus.20296 · Cited by 190
INSERM (2020) · Definitions · doi:10.32388/81w39q · Cited by 179
Van den Berg‐Vos, R. M., Franssen, H., Wokke, J. H. J., & Berg, L. H. V. D. (2002) · Brain · doi:10.1093/brain/awf193 · Cited by 168 · cited 1×
“Wrist extension 13 (15) 55 (63) 20 (23) 3.”
Self-citationvan Asseldonk, J. H., Franssen, H., van den Berg‐Vos, R. M., Wokke, J. H. J., & van den Berg, L. H. (2005) · The Lancet Neurology · doi:10.1016/s1474-4422(05)70074-0 · Cited by 151
Self-citationMultifocal motor neuropathy with and without conduction block: A single entity?
Delmont, É., Azulay, J., Giorgi, R., Attarian, S., Verschueren, A., Uzenot, D., & Pouget, J. (2006) · Neurology · doi:10.1212/01.wnl.0000234063.51897.20 · Cited by 132
Electrophysiologic findings in multifocal motor neuropathy
Katz, J., Wolfe, G. I., Bryan, W. W., Jackson, C. E., Amato, A. A., & Barohn, R. J. (1997) · Neurology · doi:10.1212/wnl.48.3.700 · Cited by 129
Vucic, S., Black, K. R., Siao, P., & Cros, D. P. (2004) · Neurology · doi:10.1212/01.wnl.0000140497.85952.fa · Cited by 127
Deterioration of multifocal motor neuropathy after plasma exchange
Carpo, M., Cappellari, A. M., Mora, G., et al. (1998) · Neurology · doi:10.1212/wnl.50.5.1480 · Cited by 121
Diagnostic value of anti-GM1 ganglioside serology and validation of the INCAT-ELISA
Kuijf, M. L., van Doorn, P. A., Tio‐Gillen, A. P., Geleijns, K. P. W., Ang, C. W., Hooijkaas, H., Hop, W. C. J., & Jacobs, B. C. (2005) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2005.07.009 · Cited by 103
Self-citationMycophenolate mofetil as adjunctive therapy for MMN patients: a randomized, controlled trial
Piepers, S., van den Berg‐Vos, R. M., der Pol, W.-L. V., Franssen, H., Wokke, J. H. J., & van den Berg, L. H. (2007) · Brain · doi:10.1093/brain/awm144 · Cited by 95
Self-citationReliability and responsiveness of a graduated tuning fork in immune mediated polyneuropathies
Merkies, I. S. J., Schmitz, P. I., van der Meché, F. G., & van Doorn, P. A. (2000) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.68.5.669 · Cited by 78 · cited 1×
“Radial 17 (20) 7 11 0 27 (31) 18 14 0 35 (41)”
Joint Task Force of the EFNS and the PNS (2006) · Journal of the Peripheral Nervous System · doi:10.1111/j.1085-9489.2006.00058.x · Cited by 78
The meaning of distal sensory loss and absent ankle reflexes in relation to age: A meta–analysis
Vrancken, A. F. J. E., Kalmijn, S., Brugman, F., Rinkel, G. J. E., & Notermans, N. C. (2006) · Journal of Neurology · doi:10.1007/s00415-005-0064-0 · Cited by 50
van Engelen, B. G. M., van Veenendaal, H., van Doorn, P. A., Faber, C. G., van der Hoeven, J. H., Janssen, N. G., Notermans, N. C., van Schaik, I. N., Visser, L. H., & Verschuuren, J. J. G. M. (2006) · Neuromuscular Disorders · doi:10.1016/j.nmd.2006.09.017 · Cited by 47
Self-citation
Cited by
Cost of disorders of the brain in Europe 2010
Gustavsson, A., Svensson, M., Jacobi, F., Allgulander, C., Alonso, J., Beghi, E., Dodel, R., Ekman, M., Faravelli, C., Fratiglioni, L., et al. (2011) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2011.08.008 · Cited by 1,723
A comprehensive review of amyotrophic lateral sclerosis
Zarei, S., Carr, K., Reiley, L., Diaz, K., Guerra, O., Altamirano, P., Pagani, W., Lodin, D., Orozco, G., & Chinea, A. (2015) · Surgical Neurology International · doi:10.4103/2152-7806.169561 · Cited by 709
Clinical diagnosis and management of amyotrophic lateral sclerosis
Hardiman, O., van den Berg, L. H., & Kiernan, M. C. (2011) · Nature Reviews Neurology · doi:10.1038/nrneurol.2011.153 · Cited by 621
Self-citationBroers, M. C., Bunschoten, C., Nieboer, D., Lingsma, H. F., & Jacobs, B. C. (2019) · Neuroepidemiology · doi:10.1159/000494291 · Cited by 195
Self-citation
Metadata
- Authors
- Cats, E. A., van der Pol, W.-L., Piepers, S., Franssen, H., Jacobs, B. C., van den Berg-Vos, R. M., Kuks, J. B., van Doorn, P. A., van Engelen, B. G., Verschuuren, J. J., Wokke, J. H., Veldink, J. H., & van den Berg, L. H.
- Venue
- Neurology
- Published
- 2010-08-31
- Volume
- 75
- Issue
- 9
- Pages
- 818-825
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- OpenAlex
- W2030866699
- Cited by
- 194
- References
- 24
- FWCI
- 9.20
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.